Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631748 · ClinicalTrials.gov registry record · NA
Quetiapine for the Reduction of Cocaine Use
A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00631748 is a NA study that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 60 participants.
The verdict
NCT00631748, a NA study, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This placebo-controlled trial will test the effectiveness of Seroquel XR™ for the treatment of cocaine dependence in non-psychotic individuals who are cocaine dependent.
Interventions
- DRUG Matched Placebo
- DRUG quetiapine fumarate
- BEHAVIORAL Cognitive-behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631748
The ClinicalTrials.gov registry entry for NCT00631748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Matched Placebo is the first listed.
NCT00631748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631748 about?
NCT00631748 is a clinical study titled "Quetiapine for the Reduction of Cocaine Use". This placebo-controlled trial will test the effectiveness of Seroquel XR™ for the treatment of cocaine dependence in non-psychotic individuals who are cocaine dependent.
What is the current status of trial NCT00631748?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-02. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00631748?
The interventions under investigation include: Matched Placebo (DRUG), quetiapine fumarate (DRUG), Cognitive-behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00631748?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.